Skip to main content

Advertisement

Log in

Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer’s disease: a meta-analysis

  • Review
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Studies of the relationship between Alzheimer’s disease (AD) and polymorphism in the promoter region of Interleukin 6 (IL-6) -174 G/C have reported inconsistent results. To assess the association between IL-6 -174 G/C promoter polymorphism and AD risk, a meta-analysis containing 3,101 AD cases and 3,860 controls from 18 case–control studies was performed. There were 16 studies involving Europeans and 2 studies involving non-Europeans. The combined results showed significant differences in recessive model [CC versus GC + GG, odds ratio (OR) = 0.70, 95% confidence interval (CI) = 0.54–0.90] and heterozygote comparison (CC versus GC, OR = 0.76, 95% CI = 0.60–0.96) on the basis of all studies. On subgroup analysis by ethnicity, similarly significant differences in recessive model (CC versus GC + GG) were found in both Europeans and non-Europeans, but significant difference in heterozygote comparison (CC versus GC) was found only in non-Europeans. In conclusion, there were statistically significant differences in genotype distribution of IL-6 -174 G/C between AD cases and controls in recessive model (CC versus GC + GG). Genotype CC of IL-6 -174 G/C could decrease the risk of AD. Further studies with large sample size, especially in subgroup analysis, should be done.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, Cazzullo CL, Vergani C, Annoni G, Clerici M (2004) Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer’s disease. Neurobiol Aging 25:1009–1015

    Article  PubMed  CAS  Google Scholar 

  2. Bagli M, Papassotiropoulos A, Knapp M, Jessen F, Luise Rao M, Maier W, Heun R (2000) Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer’s disease risk in a German population. Neurosci Lett 283:109–112

    Article  PubMed  CAS  Google Scholar 

  3. Bhojak TJ, DeKosky ST, Ganguli M, Kamboh MI (2000) Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer’s disease. Neurosci Lett 288:21–24

    Article  PubMed  CAS  Google Scholar 

  4. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3:186–191

    Article  PubMed  Google Scholar 

  5. Campbell IL, Stalder AK, Chiang CS, Bellinger R, Heyser CJ, Steffensen S, Masliah E, Powell HC, Gold LH, Henriksen SJ, Siggins GR (1997) Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry 2:125–129

    Article  PubMed  CAS  Google Scholar 

  6. Capurso C, Solfrizzi V, Colacicco AM, D’Introno A, Frisardi V, Imbimbo BP, Lorusso M, Vendemiale G, Denitto M, Santamato A, Seripa D, Pilotto A, Fiore P, Capurso A, Panza F (2010) Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry 34:177–182

    Article  PubMed  CAS  Google Scholar 

  7. Capurso C, Solfrizzi V, D’Introno A, Colacicco AM, Capurso SA, Capurso A, Panza F (2004) Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer’s disease: geographic allele and genotype variations in Europe. Exp Gerontol 39:1567–1573

    Article  PubMed  CAS  Google Scholar 

  8. Combarros O, Infante J, Llorca J, Pena N, Fernandez-Viadero C, Berciano J (2005) Interaction between interleukin-6 and intercellular adhesion molecule-1 genes and Alzheimer’s disease risk. J Neurol 252:485–487

    Article  PubMed  CAS  Google Scholar 

  9. Depboylu C, Lohmuller F, Gocke P, Du Y, Zimmer R, Gasser T, Klockgether T, Dodel RC (2004) An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer’s disease. Dement Geriatr Cogn Disord 17:170–173

    Article  PubMed  CAS  Google Scholar 

  10. Faltraco F, Burger K, Zill P, Teipel SJ, Moller HJ, Hampel H, Bondy B, Ackenheil M (2003) Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer’s disease risk. J Am Geriatr Soc 51:578–579

    Article  PubMed  Google Scholar 

  11. Fontalba A, Gutierrez O, Llorca J, Mateo I, Vazquez-Higuera JL, Berciano J, Fernandez-Luna JL, Combarros O (2009) Gene–gene interaction between CARD8 and interleukin-6 reduces Alzheimer’s disease risk. J Neurol 256:1184–1186

    Article  PubMed  Google Scholar 

  12. Infante J, Sanz C, Fernandez-Luna JL, Llorca J, Berciano J, Combarros O (2004) Gene–gene interaction between interleukin-6 and interleukin-10 reduces AD risk. Neurology 63:1135–1136

    PubMed  CAS  Google Scholar 

  13. Klimkowicz-Mrowiec A, Wolkow P, Spisak K, Maruszak A, Styczynska M, Barcikowska M, Szczudlik A, Slowik A (2010) Interleukin-6 gene–174 C/G and apolipoprotein E gene polymorphisms and the risk of Alzheimer disease in a Polish population. Neurol Neurochir Pol 44:537–541

    PubMed  Google Scholar 

  14. Koivisto AM, Helisalmi S, Pihlajamaki J, Moilanen L, Kuusisto J, Laakso M, Hiltunen M, Keijo K, Hanninen T, Helkala EL, Kervinen K, Kesaniemi YA, Soininen H (2005) Interleukin-6 promoter polymorphism and late-onset Alzheimer’s disease in the Finnish population. J Neurogenet 19:155–161

    Article  PubMed  CAS  Google Scholar 

  15. Licastro F, Grimaldi LM, Bonafe M, Martina C, Olivieri F, Cavallone L, Giovanietti S, Masliah E, Franceschi C (2003) Interleukin-6 gene alleles affect the risk of Alzheimer’s disease and levels of the cytokine in blood and brain. Neurobiol Aging 24:921–926

    Article  PubMed  CAS  Google Scholar 

  16. Mansoori N, Tripathi M, Alam R, Luthra K, Ramakrishnan L, Parveen S, Mukhopadhyay AK (2010) IL-6-174 G/C and ApoE gene polymorphisms in Alzheimer’s and vascular dementia patients attending the cognitive disorder clinic of the All India Institute of Medical Sciences, New Delhi. Dement Geriatr Cogn Disord 30:461–468

    Article  PubMed  CAS  Google Scholar 

  17. Papassotiropoulos A, Hock C, Nitsch RM (2001) Genetics of interleukin 6: implications for Alzheimer’s disease. Neurobio Aging 22:863–871

    Article  CAS  Google Scholar 

  18. Paradowski B, Celczynska D, Dodosz T, Noga L (2008) Polymorphism 174 G/C of interleukin 6 gene in Alzheimer’s disease—preliminary report. Neurol Neurochir Pol 42:312–315

    PubMed  CAS  Google Scholar 

  19. Pola R, Flex A, Gaetani E, Lago AD, Gerardino L, Pola P, Bernabei R (2002) The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer’s disease in an Italian population. Neuroreport 13:1645–1647

    Article  PubMed  CAS  Google Scholar 

  20. Ribizzi G, Fiordoro S, Barocci S, Ferrari E, Megna M (2010) Cytokine polymorphisms and Alzheimer disease: possible associations. Neurol Sci 31:321–325

    Article  PubMed  CAS  Google Scholar 

  21. Shawkatova I, Javor J, Parnicka Z, Vrazda L, Novak M, Buc M (2010) No association between cytokine gene polymorphism and risk of Alzheimer’s disease in Slovaks. Acta Neurobiol Exp 70:303–307

    Google Scholar 

  22. Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H (2002) Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype–phenotype association study in Japanese cases. Am J Med Genet 114:436–439

    Article  PubMed  Google Scholar 

  23. van Oijen M, Arp PP, de Jong FJ, Hofman A, Koudstaal PJ, Uitterlinden AG, Breteler MM (2006) Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study. Neurosci Lett 402:113–117

    Article  PubMed  Google Scholar 

  24. Vural P, Degirmencioglu S, Parildar-Karpuzoglu H, Dogru-Abbasoglu S, Hanagasi HA, Karadag B, Gurvit H, Emre M, Uysal M (2009) The combinations of TNFalpha-308 and IL-6-174 or IL-10-1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer’s disease. Acta Neurol Scand 120:396–401

    Article  PubMed  CAS  Google Scholar 

  25. Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition–the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50:2041–2056

    Article  PubMed  Google Scholar 

  26. Zhang Y, Hayes A, Pritchard A, Thaker U, Haque MS, Lemmon H, Harris J, Cumming A, Lambert JC, Chartier-Harlin MC, St Clair D, Iwatsubo T, Mann DM, Lendon CL (2004) Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer’s disease. Neurosci Lett 362:99–102

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by National Natural Science Foundation of China grant 30800441.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yun Bai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dai, L., Liu, D., Guo, H. et al. Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer’s disease: a meta-analysis. J Neurol 259, 414–419 (2012). https://doi.org/10.1007/s00415-011-6164-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-011-6164-0

Keywords

Navigation